Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(227 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
104 Records (99 escludendo Abstract e Conferenze). Impact factor totale: 450.616 (431.175 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 464.098 (443.942 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Raffaele Berisio on in data Sunday 12 July 2020, 13:15:14 203 views visite. Last view on Ultima visita in data Friday 05 February 2021, 12:53:08